CORRESP Filing
Solana Co
Date: May 28, 2025 · CIK: 0001610853 · Accession: 0001104659-25-053348
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287572
Letter
Re: Helius Medical Technologies, Inc.
May 28, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, NE
Washington, D.C. 20549
Attention: Jessica Ansart
Registration Statement on Form S-1
File No. 333-287572
Acceleration Request
Requested Date: May 29, 2025
Requested Time: 5:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Helius Medical Technologies, Inc. (the "Company" ) hereby respectfully requests that the above-referenced Registration Statement on Form S-1 (File No. 333-287572) (the "Registration Statement" ) be declared effective at the "Requested Date" and "Requested Time" set forth above, or as soon as practicable thereafter, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. The Company hereby authorizes N. Danny Shulman of Honigman LLP, counsel to the Company, to make such request on its behalf.
Please confirm the effectiveness of the Registration Statement with N. Danny Shulman of Honigman LLP by telephone at (202)899-4137.
[Signature page follows]
****
Sincerely,
Helius Medical Technologies, Inc.
Show Raw Text
CORRESP 1 filename1.htm May 28, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F. Street, NE Washington, D.C. 20549 Attention: Jessica Ansart Re: Helius Medical Technologies, Inc. Registration Statement on Form S-1 File No. 333-287572 Acceleration Request Requested Date: May 29, 2025 Requested Time: 5:00 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Helius Medical Technologies, Inc. (the "Company" ) hereby respectfully requests that the above-referenced Registration Statement on Form S-1 (File No. 333-287572) (the "Registration Statement" ) be declared effective at the "Requested Date" and "Requested Time" set forth above, or as soon as practicable thereafter, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. The Company hereby authorizes N. Danny Shulman of Honigman LLP, counsel to the Company, to make such request on its behalf. Please confirm the effectiveness of the Registration Statement with N. Danny Shulman of Honigman LLP by telephone at (202)899-4137. [Signature page follows] **** Sincerely, Helius Medical Technologies, Inc. /s/ Dane C. Andreeff Dane C. Andreeff President and Chief Executive Officer cc: Phillip D. Torrence, Honigman LLP N. Danny Shulman, Honigman LLP